Education
About Us
Working with TipRanks
Follow Us
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
4569 Stock Chart & Stats
¥1498.00
-¥23.00(-1.53%)
At close: 4:00 PM EST
¥1498.00
-¥23.00(-1.53%)
Day’s Range― - ―
52-Week Range¥1,331.00 - ¥1,698.00
Previous CloseN/A
Volume61.80K
Average Volume (3M)127.03K
Market Cap
¥78.17B
Enterprise Value¥92.33B
Total Cash (Recent Filing)¥16.62B
Total Debt (Recent Filing)¥26.48B
Price to Earnings (P/E)9.1
Beta0.51
Next Earnings
Feb 04, 2026EPS EstimateN/A
Next Dividend Ex-Date
Mar 30, 2026Dividend Yield3.5%
Share Statistics
EPS (TTM)-10.56
Shares Outstanding59,945,640
10 Day Avg. Volume147,840
30 Day Avg. Volume127,030
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)0.63
Price to Sales (P/S)0.66
P/FCF Ratio-39.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
KYORIN Pharmaceutical Co.,Ltd. News
4569 FAQ
What was KYORIN Pharmaceutical Co.,Ltd.’s price range in the past 12 months?
KYORIN Pharmaceutical Co.,Ltd. lowest stock price was ¥1331.00 and its highest was ¥1698.00 in the past 12 months.
What is KYORIN Pharmaceutical Co.,Ltd.’s market cap?
KYORIN Pharmaceutical Co.,Ltd.’s market cap is ¥78.17B.
When is KYORIN Pharmaceutical Co.,Ltd.’s upcoming earnings report date?
KYORIN Pharmaceutical Co.,Ltd.’s upcoming earnings report date is Feb 04, 2026 which is in 53 days.
How were KYORIN Pharmaceutical Co.,Ltd.’s earnings last quarter?
KYORIN Pharmaceutical Co.,Ltd. released its earnings results on Nov 07, 2025. The company reported -¥10.56 earnings per share for the quarter, missing the consensus estimate of N/A by -¥10.56.
Is KYORIN Pharmaceutical Co.,Ltd. overvalued?
According to Wall Street analysts KYORIN Pharmaceutical Co.,Ltd.’s price is currently Overvalued.
Does KYORIN Pharmaceutical Co.,Ltd. pay dividends?
KYORIN Pharmaceutical Co.,Ltd. pays a Semiannually dividend of ¥37 which represents an annual dividend yield of 3.5%. See more information on KYORIN Pharmaceutical Co.,Ltd. dividends here
What is KYORIN Pharmaceutical Co.,Ltd.’s EPS estimate?
KYORIN Pharmaceutical Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does KYORIN Pharmaceutical Co.,Ltd. have?
KYORIN Pharmaceutical Co.,Ltd. has 59,945,640 shares outstanding.
What happened to KYORIN Pharmaceutical Co.,Ltd.’s price movement after its last earnings report?
KYORIN Pharmaceutical Co.,Ltd. reported an EPS of -¥10.56 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.933%.
Which hedge fund is a major shareholder of KYORIN Pharmaceutical Co.,Ltd.?
Currently, no hedge funds are holding shares in JP:4569
Company Description
KYORIN Pharmaceutical Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd. (4569) is a Japan-based pharmaceutical company engaged in the research, development, manufacture, and marketing of prescription drugs. The company operates primarily in the fields of otolaryngology, urology, and respiratory diseases, offering a portfolio of products that includes innovative drugs, generic medicines, and over-the-counter (OTC) pharmaceuticals. KYORIN is dedicated to addressing unmet medical needs through its focus on specialty pharmaceuticals and has a strong commitment to research and development.
Technical Analysis
Kissei Pharmaceutical Co
―
Torii Pharmaceutical Co
―
Towa Pharmaceutical Co
―
Mochida Pharmaceutical Co., Ltd.
―
ASKA Pharmaceutical Holdings Co., Ltd.
―
Options Prices
Currently, No data available
---